Drug and medical-device maker Abbott Laboratories announced Friday that it will voluntarily withdraw its controversial obesity drug Meridia, (sibutramine) from the U.S. market at the request of the FDA, due to concerns it increases the risk of heart attacks and strokes.
Continue reading Abbott Pulls Weight Loss Drug Meridia from the Market
Abbott Pulls Weight Loss Drug Meridia from the Market originally appeared on DailyFinance on Fri, 08 Oct 2010 16:14:00.
Filed Under: Company News, Health Care, Abbott, Stocks in the News